Cargando…

Intravitreal Injection of Ozurdex(®) Implant in Patients with Persistent Diabetic Macular Edema, with Six-Month Follow-Up

AIM: To evaluate the efficacy of intravitreal dexamethasone injections in diabetic macular edema (DME). METHODS: A 700 μg slow-release intravitreal dexamethasone implant (Ozurdex®) was placed in the vitreal cavity of 17 patients (19 eyes) affected with persistent DME. Best corrected visual acuity (B...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacella, Fernanda, Ferraresi, Adriana Francesca, Turchetti, Paolo, Lenzi, Tommaso, Giustolisi, Rosalia, Bottone, Andrea, Fameli, Valeria, Romano, Maria Rosaria, Pacella, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852759/ https://www.ncbi.nlm.nih.gov/pubmed/27147895 http://dx.doi.org/10.4137/OED.S38028

Ejemplares similares

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema
por: Pacella, Elena, et al.
Publicado: (2013)

Five-Month Observation of Persistent Diabetic Macular Edema after Intravitreal Injection of Ozurdex Implant
por: Zalewski, Dominik, et al.
Publicado: (2014)

Dorzolamide Chlorhydrate Versus Acetazolamide in the Management of Chronic Macular Edema in Patients with Retinitis Pigmentosa: Description of Three Case Reports
por: Pacella, Elena, et al.
Publicado: (2014)

Intravitreal Dexamethasone Implant (Ozurdex) for Refractory Macular Edema Secondary to Retinitis Pigmentosa
por: Örnek, Nurgül, et al.
Publicado: (2016)

Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
por: Castro-Navarro, Verónica, et al.
Publicado: (2019)

Dexamethasone Intravitreal Implant (Ozurdex) for Long-Term Macular Edema after Epiretinal Membrane Peeling Surgery
por: Chang, Yo-Chen, et al.
Publicado: (2018)

Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017)

Evaluation of the Effect of Intravitreal Dexamethasone (Ozurdex(®)) Implant on Intraocular Pressure in Vitrectomized and Non-Vitrectomized Eyes with Macular Edema
por: Garlı, Murat, et al.
Publicado: (2021)

Short-term results of intravitreal dexamethasone implant (OZURDEX(®)) in treatment of recalcitrant diabetic macular edema: A case series
por: Rishi, Pukhraj, et al.
Publicado: (2012)

Results of intravitreal dexamethasone implant (Ozurdex(®)) for retinal vascular diseases with macular edema: An observational study of real-life situations
por: Jirarattanasopa, Pichai, et al.
Publicado: (2022)

Iatrogenic subretinal injection of Ozurdex(®) implant and its effect on macular edema
por: Karandikar, Smita Shriram, et al.
Publicado: (2017)

Spectral domain optical coherence tomography changes following intravitreal dexamethasone implant, Ozurdex(®) in patients with uveitic cystoid macular edema
por: Bansal, Pooja, et al.
Publicado: (2015)

Suspensory Materials for Surgery of Blepharoptosis: A Systematic Review of Observational Studies
por: Pacella, Elena, et al.
Publicado: (2016)

Intravitreal Ozurdex has no short term influence on choroidal thickness and vascularity index in eyes with diabetic macular edema: A pilot study
por: Rishi, Pukhraj, et al.
Publicado: (2021)

Macular Oedema Related to Idiopathic Macular Telangiectasia Type 1 Treated with Dexamethasone Intravitreal Implant (Ozurdex)
por: Loutfi, Mohamed, et al.
Publicado: (2014)

Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema
por: Mastropasqua, Rodolfo, et al.
Publicado: (2015)

Intravitreal Dexamethasone Implant (Ozurdex) in Coats’ Disease
por: Saatci, Ali Osman, et al.
Publicado: (2013)

Comparison of Two Anesthetic Methods for Intravitreal Ozurdex Injection
por: Karabaş, V. Levent, et al.
Publicado: (2015)

Fractured dexamethasone implant (OZURDEX®) following intravitreal injection
por: Aljohani, Saud M., et al.
Publicado: (2021)

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex(®)) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
por: Chan, Annie, et al.
Publicado: (2011)

Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome
por: ElBendary, Amal, et al.
Publicado: (2018)

An immunocompetent migrant presenting with neurosyphilis with an unusual unilateral papillitis: a case report
por: Turchetti, Paolo, et al.
Publicado: (2012)

Management of anterior chamber dislocation of a dexamethasone intravitreal implant: a case report
por: Pacella, Fernanda, et al.
Publicado: (2016)

A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
por: Eris, Erdem, et al.
Publicado: (2017)

PROLONGED OZURDEX-MACULAR CONTACT FOLLOWING VITRECTOMY FOR MACULAR HOLE
por: Kelkar, Aditya S., et al.
Publicado: (2019)

Efficacy of intravitreal dexamethasone implant in persistent diabetic macular edema after primary treatment with intravitreal ranibizumab
por: Özata, Kübra, et al.
Publicado: (2019)

Persistent vitreous hemorrhage after intravitreal injection of dexamethasone intravitreal implant in patients with diabetic macular edema
por: Li, Meng-Syuan, et al.
Publicado: (2019)

Effects of Repeated Intravitreal Injections of Dexamethasone Implants on Intraocular Pressure: A 4-Year Study
por: Pacella, Elena, et al.
Publicado: (2020)

Accidental Intralenticular Injection of Ozurdex® for Branch Retinal Vein Occlusion: Intact Posterior Capsule and Resolution of Macular Edema
por: Kurt, Ali, et al.
Publicado: (2019)

A surprising intravitreal injection attempt: Ozurdex™ implantation for Behçet's disease
por: Furundaoturan, Onur, et al.
Publicado: (2020)

Intravitreal Bevacizumab for Treatment of Diabetic Macular Edema
por: Seo, Jeong Won, et al.
Publicado: (2009)

Intravitreal bevacizumab and diabetic papillopathy with macular edema
por: Joob, Beuy, et al.
Publicado: (2012)

Intravitreal injection of Bevacizumab in diabetic macular edema
por: Ateeq, Asim, et al.
Publicado: (2014)

Intravitreal Therapy for Diabetic Macular Edema: An Update
por: Furino, Claudio, et al.
Publicado: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
por: Fouda, Sameh Mosaad, et al.
Publicado: (2017)

Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion–related macular edema: A systematic review and meta-analysis of randomized controlled trials
por: Hu, Qiuming, et al.
Publicado: (2019)

Efficacy and safety of 0.5% levobupivacaine versus 0.5% bupivacaine for peribulbar anesthesia
por: Pacella, Elena, et al.
Publicado: (2013)

Modified insertion technique for a sustained-release dexamethasone intravitreal implant (Ozurdex®)
por: Lee, Daniel H., et al.
Publicado: (2020)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex(®) Outcomes
por: Udaondo, Patricia, et al.
Publicado: (2021)

Comparison of Intravitreal Aflibercept and Ranibizumab following Initial Treatment with Ranibizumab in Persistent Diabetic Macular Edema
por: Demircan, Ali, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g59re079ddf9dsmf2fjk85e430